B-Cell CLL/lymphoma 6, Member B (BCL6B) Peptid
BCL6B
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle BCL6B Produkte
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- LQSDLDQPAF QQLVSFSESG SLGNSSGSDV TSLSSQLPDT PNSMVPSPVE
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of BCL6B antibody, catalog no. 70R-8459
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- BCL6B (B-Cell CLL/lymphoma 6, Member B (BCL6B))
- Synonyme
- BAZF Peptide, ZBTB28 Peptide, ZNF62 Peptide, Bazf Peptide, RGD1563179 Peptide, B-cell CLL/lymphoma 6B Peptide, B cell CLL/lymphoma 6, member B Peptide, B-cell CLL/lymphoma 6, member B Peptide, BCL6B Peptide, Bcl6b Peptide, bcl6b Peptide
-
Sie sind hier:
